SAR443820
sanofi
['sanofi']
the first-in-human phase 1 study assessing sar443820 showed potential central nervous system penetrance in health participants, with a safety profile that is safe and well-tolerated. #aanam read: 
Delivering healthcare professionals treating neurological diseases quality and relevant information to help achieve the best patient care possible. #MindMoments